Cargando…

Patients' attitude towards vaccination after Guillain Barré syndrome

BACKGROUND AND AIMS: Guillain Barré syndrome (GBS) could be triggered by an infectious disease but by vaccination as well. Thus, suffering GBS may influence patients' attitudes towards vaccination. METHODS: An anonymous questionnaire consisting of the Overall Neuropathy Limitations Score (ONLS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Holtz, Ben‐Ole, Grimm, Alexander, Axer, Hubertus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691489/
https://www.ncbi.nlm.nih.gov/pubmed/34984239
http://dx.doi.org/10.1002/hsr2.469
_version_ 1784618788204838912
author Holtz, Ben‐Ole
Grimm, Alexander
Axer, Hubertus
author_facet Holtz, Ben‐Ole
Grimm, Alexander
Axer, Hubertus
author_sort Holtz, Ben‐Ole
collection PubMed
description BACKGROUND AND AIMS: Guillain Barré syndrome (GBS) could be triggered by an infectious disease but by vaccination as well. Thus, suffering GBS may influence patients' attitudes towards vaccination. METHODS: An anonymous questionnaire consisting of the Overall Neuropathy Limitations Score (ONLS), the short form‐36 health survey (SF‐36), and questions addressing patients' attitude towards vaccination was sent to members of a German GBS support group and to patients with GBS diagnosis who were treated at Jena University Hospital. RESULTS: Ninety‐seven questionnaires clearly stated GBS as a diagnosis and were included in the analysis. Although 19.6% of the GBS patients reported having no disability in the long‐time follow‐up, a considerable number of patients still had persistent neurological symptoms; 74.2% of the GBS patients reported being able to walk at least 10 m independently. However, 5.2% were restricted to wheelchair. The patients reached lower scores in all domains of quality of life compared to German controls. Moreover, patients showed a more critical attitude towards vaccination compared to a German representative survey. Fewer patients (58.8%) received a vaccination after suffering from GBS than before (77.3%). Every tenth patient believed that vaccination was the trigger for the GBS. 32% of the patients did not receive a vaccination in the last 5 years mainly because of the fear of adverse effects (32%) or disadvise of the general practitioners (25.8%). DISCUSSION: Although the risk of relapse following immunization may be rather low, uncertainties and fears still impair the counseling of these patients by their medical practitioner.
format Online
Article
Text
id pubmed-8691489
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86914892022-01-03 Patients' attitude towards vaccination after Guillain Barré syndrome Holtz, Ben‐Ole Grimm, Alexander Axer, Hubertus Health Sci Rep Research Articles BACKGROUND AND AIMS: Guillain Barré syndrome (GBS) could be triggered by an infectious disease but by vaccination as well. Thus, suffering GBS may influence patients' attitudes towards vaccination. METHODS: An anonymous questionnaire consisting of the Overall Neuropathy Limitations Score (ONLS), the short form‐36 health survey (SF‐36), and questions addressing patients' attitude towards vaccination was sent to members of a German GBS support group and to patients with GBS diagnosis who were treated at Jena University Hospital. RESULTS: Ninety‐seven questionnaires clearly stated GBS as a diagnosis and were included in the analysis. Although 19.6% of the GBS patients reported having no disability in the long‐time follow‐up, a considerable number of patients still had persistent neurological symptoms; 74.2% of the GBS patients reported being able to walk at least 10 m independently. However, 5.2% were restricted to wheelchair. The patients reached lower scores in all domains of quality of life compared to German controls. Moreover, patients showed a more critical attitude towards vaccination compared to a German representative survey. Fewer patients (58.8%) received a vaccination after suffering from GBS than before (77.3%). Every tenth patient believed that vaccination was the trigger for the GBS. 32% of the patients did not receive a vaccination in the last 5 years mainly because of the fear of adverse effects (32%) or disadvise of the general practitioners (25.8%). DISCUSSION: Although the risk of relapse following immunization may be rather low, uncertainties and fears still impair the counseling of these patients by their medical practitioner. John Wiley and Sons Inc. 2021-12-21 /pmc/articles/PMC8691489/ /pubmed/34984239 http://dx.doi.org/10.1002/hsr2.469 Text en © 2021 The Authors. Health Science Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Holtz, Ben‐Ole
Grimm, Alexander
Axer, Hubertus
Patients' attitude towards vaccination after Guillain Barré syndrome
title Patients' attitude towards vaccination after Guillain Barré syndrome
title_full Patients' attitude towards vaccination after Guillain Barré syndrome
title_fullStr Patients' attitude towards vaccination after Guillain Barré syndrome
title_full_unstemmed Patients' attitude towards vaccination after Guillain Barré syndrome
title_short Patients' attitude towards vaccination after Guillain Barré syndrome
title_sort patients' attitude towards vaccination after guillain barré syndrome
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691489/
https://www.ncbi.nlm.nih.gov/pubmed/34984239
http://dx.doi.org/10.1002/hsr2.469
work_keys_str_mv AT holtzbenole patientsattitudetowardsvaccinationafterguillainbarresyndrome
AT grimmalexander patientsattitudetowardsvaccinationafterguillainbarresyndrome
AT axerhubertus patientsattitudetowardsvaccinationafterguillainbarresyndrome